Detalles de la búsqueda
1.
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.
Lancet
; 402(10419): 2295-2306, 2023 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37931632
2.
Preliminary validation of a questionnaire assessing psychological distress in caregivers of patients with malignant mesothelioma: Mesothelioma Psychological Distress Tool-Caregivers.
Psychooncology
; 31(1): 122-129, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34406682
3.
Epithelioid Pleural Mesothelioma Is Characterized by Tertiary Lymphoid Structures in Long Survivors: Results from the MATCH Study.
Int J Mol Sci
; 23(10)2022 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35628597
4.
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 22(10): 1438-1447, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34499874
5.
Cancer Therapy Challenge: It Is Time to Look in the "St. Patrick's Well" of the Nature.
Int J Mol Sci
; 22(19)2021 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638721
6.
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Lancet Oncol
; 21(7): 914-922, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32539942
7.
Wnt/IL-1ß/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5.
Int J Cancer
; 146(1): 192-207, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31107974
8.
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group.
Cancer
; 126(21): 4726-4734, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32749681
9.
Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial.
Lancet Oncol
; 20(12): 1702-1709, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31628016
10.
Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes.
Genes Chromosomes Cancer
; 57(11): 573-583, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30338612
11.
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma.
Br J Cancer
; 119(5): 565-571, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30057406
12.
Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial.
Lancet Oncol
; 18(9): 1261-1273, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28729154
13.
Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts.
Int J Cancer
; 140(1): 197-207, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27594045
14.
Hypophysitis Secondary to Cytotoxic T-Lymphocyte-Associated Protein 4 Blockade: Insights into Pathogenesis from an Autopsy Series.
Am J Pathol
; 186(12): 3225-3235, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27750046
15.
Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database.
Ann Surg Oncol
; 23(9): 2735-44, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27334221
16.
Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.
Genes Chromosomes Cancer
; 54(1): 51-62, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25231345
17.
Tumour Treating Fields for mesothelioma - Authors' reply.
Lancet Oncol
; 21(1): e10, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31908296
18.
BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report.
J Pers Med
; 14(4)2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38673021
19.
Pathological complete response in a patient with pleural mesothelioma treated with immunotherapy: a case report.
Front Oncol
; 14: 1378530, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38686194
20.
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund.
Tumori
; : 3008916241229287, 2024 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38372045